Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome

Cancer

Volumn 115, Issue 12, 2009, Pages 2701-2709

  Alos, Llucia ^a,d   Moyano, Susana ^a   Nadal, Alfons ^a   Alobid, Isam ^a   Blanch, Jose L ^a   Ayala, Edgar ^a   Lloveras, Belén ^b   Quint, Wim ^c   Cardesa, Antonio ^a   Ordi, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c DDL DIAGNOSTIC LABORATORY   (Netherlands)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Human papillomavirus; p16; Prognosis; Sinonasal; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINONASAL SQUAMOUS CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARANASAL SINUS NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 67649207248     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24309     Document Type: Article

References (40)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. (Pubitemid 29406813)
3. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162:747-753. (Pubitemid 36237483)
4. Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol. 2003;16:692-699.
5. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211-1218. (Pubitemid 32947950)
6. Santos M, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol. 2006;30:1347-1356. (Pubitemid 44655467)
7. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956. (Pubitemid 46740304)
8. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720. (Pubitemid 30365531)
9. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-1783. (Pubitemid 38008900)
10. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619. (Pubitemid 351264356)
11. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
12. Li W, Thompson CH, O'Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003;106:553-558. (Pubitemid 36966212)
13. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813. (Pubitemid 32783066)
14. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-3137.
15. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26:3138-3146.
16. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S11-S25. (Pubitemid 44404053)
17. National history and epidemiology of HPV infection. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 90: Human papillomaviruses. Lyon International Agency for Research on Cancer. 2007:68-92.
18. Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol. 2003;56:174-181. (Pubitemid 36308030)
19. Hoffmann M, Klose N, Gottschlich S, et al. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett. 2006;239:64-70. (Pubitemid 43946576)
20. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367-1372. (Pubitemid 41368773)
21. Greene FI, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. Berlin, Germany: Springer; 2002.
22. Pilch BZ, Bouquot J, Thompson LDR. Squamous cell carcinoma of the nasal cavity and paranasal sinuses (sinonasal carcinoma). In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Head and Neck Tumours. Lyon, France: World Health Organization; 2004:15-17.
23. Horn LC, Reichert A, Oster A, et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2008;32:502-512.
24. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399. (Pubitemid 35239415)
25. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
26. Ayiomamitis A, Parker L, Havas T. The epidemiology of malignant neoplasms of the nasal cavities, the paranasal sinuses and the middle ear in Canada. Arch Otorhinolaryngol. 1988;244:367-371. (Pubitemid 18054468)
27. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer. 2001;92:3012-3029. (Pubitemid 33136196)
28. Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci. 1980;5:195-211. (Pubitemid 10073630)
29. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287. (Pubitemid 18141930)
30. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463-1470. (Pubitemid 37315200)
31. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol. 1995;7:229-233.
32. Todd R, Donoff RB, Wong DT. The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg. 1997;55:613-623. (Pubitemid 27259789)
33. Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer. 2003;107:394-400. (Pubitemid 37266459)
34. Scholes AG, Liloglou T, Snijders PJ, et al. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer. 1997;71:796-799. (Pubitemid 27237201)
35. van Houten V, Snijders PJ, van den Brekel MW, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001;93:232-235. (Pubitemid 32574279)
36. Buchwald C, Lindeberg H, Pedersen BL, Franzmann MB. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope. 2001;111:1104-1110.
37. Shen J, Tate JE, Crum CP, Goodman ML. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol. 1996;9:15-20. (Pubitemid 26061950)
38. Bernauer HS, Welkoborsky HJ, Tilling A, Amedee RG, Mann WJ. Inverted papillomas of the paranasal sinuses and the nasal cavity: DNA indices and HPV infection. Am J Rhinol. 1997;11:155-160. (Pubitemid 127773021)
39. Weber RS, Shillitoe EJ, Robbins KT, et al. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988;114:23-26. (Pubitemid 18031592)
40. Syrjanen K, Syrjanen S.Papillomavirus Infections in Human Disease. New York, NY:Wiley; 2000:1-615.